InvestorsHub Logo
icon url

goodthings

08/17/20 4:10 PM

#90788 RE: Raffis #90780

Bloomberg on Aug. 16 : The Yale researchers said they aren't seeking to commercialize the method, according to the university's website. While this is the fifth that the FDA has authorized that uses saliva as a sample for testing, it may be the "lowest cost test to hit market with ability to be pooled," Scott Gottlieb, former head of the U.S. Food and Drug Administration said in a tweet.


Why don't you reread the Quarterly Report??
--- CEO Berman confessed that DECN serology test kits have a lack of accuracy .
(i.e. false negatives = Low sensitivity).

Then do you really think DECN serology test kits and saliva test kit have the ability to detect people infected with COVID-19 with "high" sensitivity???